CGTN: Challenges, Goals and Proposals From Communique of China's Ruling Party Plenum

 BEIJING-Sunday 1 November 2020 [ AETOS Wire ]

(BUSINESS WIRE) -- The 19th Central Committee of the Communist Party of China (CPC) concluded its fifth plenary session in Beijing on Thursday with the release of a communique.

The 14th Five-Year Plan (FYP) (2021-2025) for National Economic and Social Development and the Long-Range Objectives Through the Year 2035 are the key topics of the communique.

Here is a look at all the highlights from the communique of the meeting.

Read the original article: here.

Decisive success made in building a moderately prosperous society in all respects

This year is the final year of China's 13th FYP period (2016-2020) and the communique highlighted that the implementation of the 13th FYP has been smooth.

By adhering to the new development concept and unswervingly advancing reform and opening-up, great achievements have been made since the fourth plenary session, the communique said.

During the past year, China has deepened supply-side reform, enhanced macro-economic regulation and expanded domestic demand as the strategic foundation.

Economic growth has been better than expected, people's livelihood has been improved and social stability has been maintained.

During the 13th FYP period, which is coming to an end in 2020, China has made great progress with stable economic growth and better economic structure, the communique said, noting China's GDP is expected to surpass the 100 trillion yuan ($14.9 trillion) mark in 2020.

More than 55 million people in China have been lifted out of poverty in the past five years.

China has built the world's largest social security system in the 13th FYP period, the communique said, adding that the country's basic medical insurance has covered over 1.3 billion people, and basic old-age insurance has covered nearly 1 billion people.

Meanwhile, during the past five years, more than 60 million new jobs were created in China's urban areas, it said.

As for the fight against the COVID-19 pandemic, the whole country coordinated the prevention and control work with economic and social development and put people's safety and health first.

Major country diplomacy with Chinese characteristics was vigorously promoted, and major achievements were made in various undertakings of the Party and state.

The strength of the leadership of the CPC and the Chinese socialist system has been further demonstrated in the past five years, it added.

New challenges, opportunities and proposals ahead

With regards to the blueprint for the future, the communique stressed that the whole Party must take into account the overall strategic plan for the great rejuvenation of the Chinese nation with major changes in the world that have not occurred in a century.

A thorough understanding is necessary about the new characteristics and requirements brought about by the changes in the evolution of the principal contradiction facing Chinese society, it said.

Also, given that China is in the primary stage of socialism, more attention should be paid to the new contradictions and challenges brought by the complex international environment.

The communique underlined the importance of strengthening awareness of opportunities and risks and cultivating opportunities amid crisis.

Additionally, the CPC has raised a set of long-range objectives for China to achieve socialist modernization by 2035.

China's economic, technological and composite strength was also stressed, as well as development in new industrialization and the modernization of China's system and capacity for governance.

The communique also said effort was needed in boosting the well-rounded development of society, including social etiquette and civility and the advancement of eco-friendly ways of work and life.

China's opening-up, per capita GDP, the implementation of the Peaceful China initiative and well-rounded human development were also highlighted.

As for the goals to be reached during the 14 FYP period, the communique said that the overall leadership of the CPC must be upheld to realize the 14th FYP and efforts should be made to mobilize all positive factors and rally all the forces that can be rallied to form a strong synergy to promote development.

Several proposals to reach the goals

- Upholding the central role of innovation in its modernization drive and implementing the innovation-driven strategy.

- Building a modern industrial system and upgrading the economic structure. It will continue to support the real economy, improve manufacturing power and modernized industrial chain and supply chain, so as to improve high-quality growth and core competitiveness.

- Nurturing a strong domestic market and establishing a new development pattern. The country will smooth domestic circulation and let domestic and international circulations reinforce each other, spurring consumption in an all-round way and expanding investment.

- Deepening reform comprehensively in pursuit of a high-level socialist market economy.

- Prioritizing the development of agriculture and rural areas, and fully advancing rural vitalization.

- Advancing coordinated regional development and a new type of urbanization.

- Promoting cultural sector and improving its cultural soft power.

- Accelerating green and low-carbon development, continuously improving the environment as well as the quality and stability of ecosystems, and raising the efficiency of resource utilization.

- Pursuing high-level opening-up and exploring new prospects of win-win cooperation.

It will continue to widen the opening-up and leverage the advantages of its huge market to promote international cooperation and achieve win-win results.

- Improving people's standard of living, and actively implementing strategies to address ageing population.

- Strengthening national security capabilities and increasing the capacity to deal with traditional and non-traditional security challenges, so as to protect people's lives and security and maintain social stability.

- Maintaining the long-term prosperity and stability of the Hong Kong and Macao special administrative regions, and promoting the reunification of Chinese mainland and Taiwan as well as peaceful Cross-Strait development.

It aims to keep a stable external environment and promote the building of a new type of international relations and a community with a shared future for mankind.

A total of 198 members and 166 alternate members of the CPC Central Committee attended the meeting.

Also present were members of the Standing Committee of the CPC Central Commission for Discipline Inspection and senior officials of relevant sectors, as well as experts, scholars and several deputies of the 19th CPC National Congress who work at the grassroots level.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201029006395/en/

 

Contacts

Media:
Jiang Simin
jiang.simin@cgtn.com
+86 18826553286

Permalink : https://www.aetoswire.com/news/cgtn-challenges-goals-and-proposals-from-communique-of-china39s-ruling-party-plenum/en

Australia’s Global Talent Visa Program Sees Tech CEOs Swap Silicon Valley for Sydney

 LONDON-Wednesday 28 October 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- Australia’s Global Talent Visa Program, also known as the Global Talent Independent Program, is making waves across the Pacific, attracting dynamic, high-profile business leaders to the country’s shores, with many hailing from the US. The program is fine tuned to attract only the world’s premium business talent, and this highly targeted approach has proven to be a great success as clients include top Palo Alto executives and leading Tech CEOs.

The program is aimed at highly skilled individuals and high-income earners and was expressly designed to grow Australia’s innovation and tech economies. The seven future-focused target sectors: AgTech, Space and Advanced Manufacturing, FinTech, Energy and Mining Technology, MedTech, Cyber Security, and Quantum Information, Advanced Digital, Data Science and ICT. With no age limit or investment prerequisite, the only requirements for applicants are to be internationally recognized, prominent in their field, and able to provide evidence of outstanding achievements. There are 15,000 places available in 2020–2021, and successful applicants can obtain fast-tracked permanent residence for the whole family within six weeks and have a full five years to make the move Down Under. Places are also available to internationally recognized master’s and PhD students who can demonstrate their exceptional talent.

Director of leading international citizenship and residence advisory firm Henley & Partners’ Australia office, Tony Le Nevez, says the country’s prosperity, safety, and excellent quality of life make it a highly sought-after destination for high-net-worth individuals and entrepreneurs. “Stimulating innovation — and tech innovation in particular — should be a non-negotiable for any sovereign state in the current context. By attracting and harnessing the world’s cutting-edge talent, Australia’s permanent residence offering will ensure that the country stays well ahead of the game. The coronavirus-related events of 2020 have provoked a desire for change, leading many individuals to seek out alternative options. We have seen a huge spike globally in interest in investment migration programs, and from Americans in particular. The Global Talent Visa Program presents a perfect opportunity for matching top global talent with a safe, reliable, and successful country that is forward looking.”

Dominic Volek, Henley & Partners Group Head of Private Clients, says “Contrary to what many believe, residence and citizenship programs are not the exclusive domain of nations that are struggling economically or starved of foreign capital. Nineteen of the Group of 20 nations, including the UK and the US, offer a mechanism to attract inward investment in exchange for residence rights. Sixty percent of EU member states offer investment migration programs. These highly developed nations design and implement these programs for the same reasons small and developing nations do — to attract foreign capital, skills, and knowledge to stimulate their domestic economies.”

For successful HNWI who might not be the next Steve Jobs, Australia offers various pathways to permanent residence. Under the Skilled – Investment/Entrepreneurial program there are six main streams for business innovators, investors, significant investors, entrepreneurs, business talent, and venture capitalist entrepreneurs, with minimum requirements ranging from business turnover of AUD 500,000 and net assets of AUD 800,000 (Business Innovation stream) to committing at least AUD 5 million into a complying Australian investment for at least four years (Significant Investor stream). If Australia appeals, it is advisable to apply in the next six to eight months, as significant changes are on the horizon with an announcement expected in July 2021.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201028005616/en/

Contacts

Media Contact

Alina Morais

Head of PR: Southeast Asia

alina.morais@henleyglobal.com

Permalink : https://www.aetoswire.com/news/australiarsquos-global-talent-visa-program-sees-tech-ceos-swap-silicon-valley-for-sydney/en

HKTDC Autumn Sourcing Week | ONLINE Opens in Nov

 

HONG KONG-Sunday 1 November 2020 [ AETOS Wire ]

(BUSINESS WIRE) -- Hong Kong, while the COVID-19 outbreak continues to hamper global business activities, online sourcing has become the ultimate solution that makes trade transactions possible. Riding on the success of the debut Summer Sourcing Weeks | Go ONLINE, the HKTDC is organising its next online exhibition from 16-27 November, Autumn Sourcing Week | ONLINE (ASWO).

Benjamin Chau, HKTDC Deputy Executive Director, said: “The uncertainties brought by the COVID-19 pandemic have led more small and medium-sized enterprises (SMEs) to focus on online promotions and operations, which has quickly become the ‘new normal’ for conducting business. Given that the pandemic has prevented buyers and exhibitors from meeting in person, the HKTDC has introduced online business matching to enable networking and deal-making.”

Under the theme of “A New Connected World Beyond the New Normal”, ASWO once again offers a one-stop online sourcing platform for buyers and suppliers to continue exploring more business opportunities across various industries including electronics, houseware, lighting, outdoor tech light, eco tech, gifts & premium, toys, baby products, stationery, optical as well as watch & clock, during these trying times. A series of webinars will be hosted on Intelligence Hub, with 70+ global business leaders and experts sharing their insights in the above mentioned 11 industries.

Backed by the HKTDC’s global network of 50 offices and a powerful database, ASWO’s exhibition team provides excellent customer service, pre-arranges business matching meetings with on-target partners and unveils the latest industry trends and developments for participants. What’s more, ASWO continues to utilise “Click2Match”, an AI-enabled business matching platform, to provide buyers and suppliers with online self-service tools such as meeting planner, live chat, video meeting, and e-business card exchange.

Trade buyers, register Now to enjoy a hassle-free online sourcing and networking journey:

https://bit.ly/3kocbEX

View source version on businesswire.com: https://www.businesswire.com/news/home/20201029006379/en/

Contacts

Hong Kong Trade Development Council
Doris Cheng doris.py.cheng@hktdc.org





Permalink : https://www.aetoswire.com/news/hktdc-autumn-sourcing-week-online-opens-in-nov/en

Boehringer Ingelheim Begins Phase 2 Clinical Trial of a Targeted Therapy to Help People with Severe Respiratory Illness from COVID-19

 • Trial will evaluate BI 764198, a novel first-in-class compound, for hospitalized people infected with SARS-CoV-2 with severe respiratory complications for which very limited treatment options are currently available.

• This new therapeutic option could help the 67-85% of COVID-19 patients admitted to the intensive care unit who suffer from acute respiratory distress syndrome,1 potentially reducing the need for mechanical ventilation and potentially saving lives.

• The initiation of this Phase 2 trial is part of Boehringer Ingelheim’s ongoing efforts to accelerate the discovery and development of urgently needed medicines for COVID-19 patients.

INGELHEIM, Germany-Wednesday 28 October 2020 [ AETOS Wire ]

(BUSINESS WIRE) -- Boehringer Ingelheim today announced the initiation of a Phase 2 clinical trial of BI 764198, an inhibitor of TRPC6, a receptor-operated cation channel. This potent and selective inhibitor of TRPC6 may alleviate the damage to the lung and decrease the risk or severity of acute respiratory complications in patients hospitalized for COVID-19. The aim of therapy with BI 764198 is to reduce the need for ventilator support, to improve patient recovery rate and ultimately to save lives. Boehringer Ingelheim is committed to fighting COVID-19 and contributing with its expertise and resources to develop new therapeutic options for patients suffering from the virus’ severe complications.

“COVID-19 can cause serious lung complications, such as viral pneumonia, and in severe cases can lead to acute respiratory distress syndrome (ARDS) and lung failure,” said Dr. Lorraine B. Ware, Ralph and Lulu Oven Endowed Chair and Professor of Medicine, and Pathology, Microbiology and Immunology, Vanderbilt University. “Patients hospitalized with ARDS due to COVID-19 are often unable to breathe on their own and may require life support from a mechanical ventilator to help supply oxygen to the body. While we hope that future vaccines will help reduce cases of severe COVID-19, there remains an unmet need to address respiratory complications in infected patients, and provide healthcare professionals an effective alternative to mechanical ventilation that can potentially reduce the treatment burden within the hospital setting.”

Approximately 15% of patients infected with SARS-CoV-2 develop severe disease and up to 30% of severely ill patients may require medical care in an intensive care unit (ICU). Between 67 and 85 percent of patients in the ICU develop ARDS, a potentially deadly complication of severe COVID-19.1 Therapeutic options, such as BI 764198, are urgently needed to reduce severe respiratory distress, save lives and ultimately help reduce the incredible burden the virus is placing on healthcare systems.

“This therapy may provide the first potential treatment for COVID-19 related respiratory distress syndrome, helping to close a significant gap in the treatment regimen for COVID-19 patients. As we have understood more in recent months about the pathology of this disease, we realized that BI 764198 might have a unique potential to help the most severely affected patients and we felt compelled to bring it to clinical studies,” said Dr. Mehdi Shahidi, Corporate Senior Vice President Medicine and Chief Medical Officer, Boehringer Ingelheim. “It is our hope that this step forward will provide treating physicians with a new tool to improve the outlook for their hospitalized patients affected by the respiratory complications of COVID-19.”

As a research-driven company, Boehringer Ingelheim is part of the collective effort in fighting COVID-19. Drawing from their areas of expertise, the company has engaged in a number of activities to find medical solutions to this pandemic, working closely with academic researchers, international institutions, and others in the pharma industry. Boehringer Ingelheim is currently involved in a broad set of initiatives to fight the disease and save patients’ lives, including the research and development of SARS-CoV-2 antibodies that can neutralize the virus, small molecules to inhibit its replication, and therapy development to prevent microcoagulation (blood clots). Boehringer Ingelheim is also an active participant in the global access initiative with the Bill and Melinda Gates Foundation as well as global development initiatives including the COVID-19 Therapeutics Accelerator (CTA) and the CARE Consortium.

About the Study

This Phase 2 randomized double-blind placebo-controlled trial will evaluate BI 764198 in patients hospitalized for COVID-19 with participants taking one capsule per day for up to four weeks. The primary endpoint will be the percentage of patients who are alive and free of mechanical ventilation at day 29 of treatment. Other endpoints include clinical improvement, oxygen saturation and ICU admission. In patients hospitalized for COVID-19, there is an increase in reactive oxygen species (ROS) due to airway injury. ROS have been shown to activate TRPC6, which may cause a cascade of cellular damage resulting in disruption of cellular barrier function, hyper-permeability, edema and ultimately acute respiratory distress syndrome (ARDS). BI 764198 treatment in animal models of lung injury has been shown to reduce cellular damage and lung edema. Treatment with BI 764198 may provide similar benefits in patients with severe SARS-CoV-2 infection. BI 764198 has been shown to be well tolerated in a previous Phase 1 study in healthy adults (NCT03854552).

Trial enrollment for BI 764198 is expected to begin in October 2020 and will include approximately 40 study sites across eight countries. For more information, please visit: https://clinicaltrials.gov/ct2/show/NCT04604184?cond=covid&spons=Boehringer&draw=2&rank=1 and https://www.mystudywindow.com/?global=1

Please click on the link for ‘Notes to Editors’ and ‘References’:

https://www.boehringer-ingelheim.com/press-release/developing-potential-treatment-severe-covid19-complications

View source version on businesswire.com: https://www.businesswire.com/news/home/20201028005648/en/

Contacts

Media Contacts

Dr. Reinhard Malin

Head of Communications Innovation Unit

Boehringer Ingelheim Corporate Center GmbH

Media + PR

P: +49 6132 77-90815

reinhard.malin@boehringer-ingelheim.com

Linda Ruckel

Senior Associate Director, Media and Corporate Reputation

Boehringer Ingelheim U.S.

Media + PR

P: +1 203-791-6672

linda.ruckel@boehringer-ingelheim.com

Permalink : https://www.aetoswire.com/news/boehringer-ingelheim-begins-phase-2-clinical-trial-of-a-targeted-therapy-to-help-people-with-severe-respiratory-illness-from-covid-19/en

Bluemina Citizenship & Residency Opens New Office in Sheikh Zayed City – Egypt

 Cairo, Arab Republic of Egypt-Sunday 1 November 2020 [ AETOS Wire ]

World-Leading consultancy firm Bluemina Citizenship & Residency continued its expansion by opening a new office in Cairo, Egypt. The office will provide consultancy services related to obtaining second citizenship, Second Passports & permanent residency by investment, and includes a team of experts to cater to the needs of investors and businessmen in North Africa, as well as a broad base of distinguished clients in the Arab Republic of Egypt.

The launch falls in line with Bluemina Citizenship & Residency’s efforts to increase its presence in the MENA region and meet the growing surge in demand for second citizenship and permanent residency by investment programs.

Bluemina’s new office expands its operations in the Egyptian investment market. With a growing team of seasoned advisors, the company seeks to cater to the needs of individuals wishing to explore new and available business opportunities in the region, and receive the many benefits offered by a second passport and residency-by-investment programs, which will enable them to advance their business without the need to renounce their existing or original citizenship.

Mr. Wasim Daoud, Bluemina’s Founder and CEO noted that the new office was mainly established to cater to the fast-growing needs of investors and individuals in the Egyptian market. “The new office is Bluemina’s response for the increasing demand for second passport programs and citizenship and residency services. Investors or individuals wishing to acquire a second passport or a permanent residency in any European country or any  of the UK’s Commonwealth of Nations may leverage the many benefits of these programs, including the freedom of travel around the world and the right to guarantee the future of their children and grandchildren, as well as access to unlimited business and investment opportunities”, said Mr. Daoud. He also invited interested parties to visit the new office, located in Office 202, Building #B2, Administrative Complex, Capital Business Park, the Central Axis, Sheikh Zayed City, Giza, and benefit from free consultancy services provided by the team of experienced advisors, who will guide them through the process to choose the most suitable program.

Bluemina Citizenship & Residency offers second citizenship, second passport, and permanent residency-by-investment services. The company provides individuals, families and investors with the best and most expedited citizenship and permanent residency programs tailored to their specific needs. We offer smooth and transparent processes that substantially streamline the process of obtaining a Caribbean passport, such as Saint Kitts and Nevis, Dominica, Saint Lucia, Grenada and Vanuatu passports; or a European passport, such as Malta, Portugal, Greece, Cyprus, Turkey, Montenegro and North Macedonia; or the United States' Green Card program (US-EB-5).

Bluemina Citizenship & Residency began further expanding its footprint in the Arab region since 2003, by moving its Operations HQ to Jordan, and establishing several offices in Egypt, the United Arab Emirates, Iraq, Palestine, Qatar and other Arab countries.

 

Contacts

Bashir Mraish Consultancy

0096279602000

www.bashirmraish.com

Permalink : https://www.aetoswire.com/news/bluemina-citizenship-amp-residency-opens-new-office-in-sheikh-zayed-city-ndash-egypt/en

INX Applies for Listing on the Canadian Securities Exchange (CSE)

 Application represents the next step towards digital securities trading on a traditional exchange

NEW YORK & TORONTO-Sunday 1 November 2020 [ AETOS Wire ]

(BUSINESS WIRE) -- INX Limited (“INX”) today announced its application for listing of its digital security, the INX Token, on the Canadian Securities Exchange (“CSE”). The listing application is subject to the approval of the CSE.

INX recently launched the first SEC-registered digital security IPO for both retail and institutional investors. INX intends to use the net proceeds from the IPO for a launch of a regulated trading platform for digital assets and provide novel trading and capital raising financial instruments to enterprises in collaboration with traditional exchanges worldwide. The CSE is a proponent of exchange-listed digital securities and continues to work towards additional services in connection with the post-trade processes for these securities.

Richard Carleton, CEO of the CSE has stated that “The CSE is working hard towards listing solutions that cater to a rapidly changing and increasingly digitized capital markets environment. Digital securities represent a logical evolution in how investment instruments are constructed, issued, and traded on a regulated marketplace. It comes as no surprise that new product innovations are originating from Israel, where the culture of entrepreneurship and technical leadership are a perfect fit with our exchange.”

Shy Datika, Co-Founder and President of INX commented that “Digital securities represent new opportunities in regulated cross-border trading and multi-listings. It is a new era in capital markets where each listed security can be seamlessly traded on multiple exchanges providing much higher access to capital and liquidity for each trading asset.”

About INX

INX aims to provide a regulated trading platform for digital securities combining traditional markets expertise and a novel fintech approach. INX is led by an experienced team of business, finance, and blockchain technology experts unified by the vision of redefining the world of capital markets via the leveraging of blockchain technology and novel regulatory approach.

Forward-Looking Statements

Some of the statements in this press release constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “plans,” “project,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “intends,” or “continue,” or the negative of these terms or other comparable terminology. These forward-looking statements may include, but are not limited to, statements relating to our objectives, plans, and strategies; statements that contain projections of results of operations or of financial condition; statements relating to the research, development, and use of our products; and all statements (other than statements of historical facts) that address activities, events, or developments that we intend, expect, project, believe, or anticipate will or may occur in the future. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. We have based these forward-looking statements on assumptions and assessments made by our management in light of their experience and their perception of historical trends, current conditions, expected future developments, and other factors they believe to be appropriate. These statements are only current predictions and are subject to known and unknown risks, uncertainties, and other factors that may cause our or our industry’s actual results, levels of activity, performance, or achievements to be materially different from those anticipated by the forward-looking statements. We discuss many of these risks in greater detail in the prospectus that forms a part of the effective registration statement filed with the SEC, including under the headings “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements.” You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable as of the date hereof, we cannot guarantee future results, levels of activity, performance, or achievements. Except as required by law, we are under no duty to update or revise any of the forward-looking statements, whether as a result of new information, future events or otherwise.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201030005313/en/

Contacts

Alona Stein

ReBlonde for INX

alona@reblonde.com

Permalink : https://www.aetoswire.com/news/inx-applies-for-listing-on-the-canadian-securities-exchange-cse/en

Stars of Science Top Four Innovators Advance to Grand Final

 Finalists on QF TV Show compete for share of $600,000 seed fund and status of Arab world’s top innovator

Doha, Qatar-Sunday 1 November 2020 [ AETOS Wire ]

Four inventors on Qatar Foundation’s Star of Science set themselves apart this season, overcoming challenges posed by COVID-19, and earning their places in the Grand Finale.  

In this week’s prototype testing episode, Ahmed Fathalla, Eiman Al Hamad, Mohammad Almogahwi, Sarah Aboerjaib, and Wadah Malaeb took to the stage to prove that their projects met consumer needs, conducting user testing on their inventions.

“These talented Arab youths overcame incredible odds to reach this point in Season 12; conceiving and constructing their inventions under challenging circumstances and the eye of a watchful jury has been inspiring,” said Khalid Al Jumaily, Stars of Science’s long-time host.

“Everyone on the show, from the contestants to the experts and jury, showed perseverance and an unyielding dedication to scientific excellence. Stars of Science upholds a tradition of technological discovery and innovative thinking in the Arab region, and this season is no different.”

Two of the contestants excelled during prototype testing. Wadah made great progress on his Ductal Organoid-on-a-Chip, pitching his idea to experts and potential users to gain validation of his product, while Eiman’s Arabic Conversation Fraud Detection program impressed experts as they praised its huge scale and ambition.

However, Mohammad’s Automated Hands-free Toothbrush made the user uncomfortable during testing, with its large size and the excessive amount of water used. Ahmed’s Educational Platform using Electronic Cubes engaged one young user, but it occasionally failed to register some of the child’s behaviors, and the data presented was unclear.

But it was Sarah who was ultimately sent home. Her Fractured Bone Optical Scanner failed to show convincing results, and the jury criticized the lack of comprehensive testing and deemed the project unproven. Despite being voted out, the Kuwaiti remained confident in her project, pledging to continue its development in the future. “My departure from the show does not imply that my idea was a failure, it just simply didn’t fit the criteria of the jury,” she said.

Mohammed Al-Jefairi, a top four finalist on Season 9, assumed the role of co-host alongside Khalid Al Jumaily. He also told contestants that Stars of Science is only the beginning of their innovation journeys and that they must take advantage of the show’s alumni network in the future.

Ahmed, Eiman, Mohammad, and Wadah will make the case for their inventions in the Grand Final airing on Friday, November 6, showing off their market readiness and determining their final share of the $600,000 seed fund. Online viewers will also help determine the winner, as their votes count for 50 percent of the final score.

Online voting is now open on www.starsofscience.com and ends on Thursday, November 5, at 3PM GMT.

About Stars of Science

As the premier innovation show in the Arab world, Stars of Science – the edutainment TV initiative of Qatar Foundation (QF) – empowers Arab innovators to develop technological solutions for their communities, benefitting people’s health and lifestyles, and helping to preserve the environment.

Over a 12-week process, the contestants demonstrate the effectiveness of their solutions in a shared innovation space, competing against time with the support of a team of experienced engineers and product developers. An expert panel of jurors assess and eliminate projects every week across several prototyping and testing rounds, until only four finalists remain to compete for a share of $600,000 in seed funding. Jury deliberation and online voting from the public determine the rankings.

Stars of Science will air every Friday and Saturday from September 11, 2020 till November 6, 2020. Please visit the broadcast guide for channels and timings: starsofscience.com 

Please visit:

Website - www.starsofscience.com

Facebook - https://www.facebook.com/StarsofScienceTV

Twitter - https://twitter.com/starsofscience

YouTube- http://www.youtube.com/user/Starsofsciencetv

Instagram- starsofsciencetv

Tik Tok- starsofscience

Qatar Foundation – Unlocking Human Potential

Qatar Foundation for Education, Science and Community Development (QF) is a non-profit organization that supports Qatar on its journey to becoming a diversified and sustainable economy. QF strives to serve the people of Qatar and beyond by providing specialized programs across its innovation-focused ecosystem of education, science and research, and community development.

QF was founded in 1995 by His Highness Sheikh Hamad bin Khalifa Al Thani, the Father Amir, and Her Highness Sheikha Moza bint Nasser, who shared the vision to provide Qatar with quality education. Today, QF’s world-class education system offers lifelong learning opportunities to community members as young as six months through to doctoral level, enabling graduates to thrive in a global environment and contribute to the nation’s development.

QF is also creating a multidisciplinary innovation hub in Qatar, where homegrown researchers are working to address local and global challenges. By promoting a culture of lifelong learning and fostering social engagement through programs that embody Qatari culture, QF is committed to empowering the local community and contributing to a better world for all.

For a complete list of QF’s initiatives and projects, visit http://www.qf.org.qa

Contacts

Weber Shandwick

Maram Alibrahim

SOS@webershandwick.com

+974 3398 8390

Permalink : https://www.aetoswire.com/news/stars-of-science-top-four-innovators-advance-to-grand-final/en